Xin Lang Cai Jing·2025-12-10 11:50Group 1 - The core viewpoint of the article is that JD Health is expected to achieve significant revenue and profit growth in 2025, with forecasts indicating a revenue range of 70.823 to 71.498 billion yuan, representing a year-on-year growth of 21.8% to 22.9% [1][8] - The expected net profit for JD Health in 2025 is projected to be between 4.416 to 5.261 billion yuan, showing a year-on-year increase of 6.1% to 26.4% [1][8] - The adjusted net profit is anticipated to be in the range of 5.665 to 6.342 billion yuan, reflecting a growth of 18.2% to 32.3% year-on-year [1][8] Group 2 - According to Haitong International Securities, JD Health's Q3 2025 performance showed strong growth, with revenue reaching 17.12 billion yuan, a year-on-year increase of 28.7%, and net profit of 1.84 billion yuan, up 97.2% [5][11] - The company has raised its full-year guidance, expecting a revenue growth of approximately 22.0% and an adjusted profit of around 6.20 billion yuan [5][11] - The growth is attributed to high performance in the pharmaceutical category and advertising business, as well as effective marketing investments [5][11] Group 3 - Minsheng Securities reported that JD Health's Q3 2025 revenue was 17.12 billion yuan, with operating profit and Non-IFRS profit increasing by 125.3% and 42.4% year-on-year, respectively [6][12] - The company has made significant progress in expanding online medical insurance payments, with coverage reaching nearly 200 million people and over 150,000 merchants on the platform [6][12] - JD Health has signed strategic cooperation agreements with several well-known pharmaceutical companies to strengthen its position in the high-end pharmaceutical supply chain [6][12]